Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can text reminders and training tame high blood pressure?

NCT ID NCT06871462

Disease control Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Aug 21, 2026 · Updated 2 times

Summary

This study tests different strategies to help people from diverse backgrounds monitor their blood pressure at home. About 330 adults with uncontrolled high blood pressure will receive training on using a blood pressure monitor and a mobile app, plus SMS reminders and education. The goal is to see if these tools safely improve blood pressure control and are cost-effective.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
behavioral interventions (training, SMS reminders, education)
What this could lead to
If successful, this could show simple, low-cost ways to help people from different backgrounds better manage their blood pressure at home.
What could go wrong
This is an early-stage implementation study, not a drug trial. Results may vary by clinic and patient group, and improvements might be small or hard to sustain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 330 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years old/order * Any sex or gender * Any race or ethnicity * Must be receiving primary care at any of the six enrolled clinics * Have uncontrolled hypertension (two clinic BP readings ≥140/90 mmHg within the previous 18 months) * Can read and write English, Spanish, or Cantonese * Be able to provide consent * Must own a cell phone that receives SMS or text messages Exclusion Criteria: * Those with conditions that might complicate remote BP monitoring: * Pregnancy (and 12 months postpartum) * Acute myocardial infarction or stroke in the last 12 months * End-stage renal disease on dialysis * Stage D heart failure * Active treatment for cancer (except for nonmelanoma skin cancers) * Pacemaker use * Those with dementia, in hospice care, or with serious behavioral health conditions impeding participation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Blood pressure monitoring, home are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertensive disorder Respiratory Aspiration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Blood pressure monitoring, home Hypertension

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Zuckerberg San Francisco General Hospital

    San Francisco, California, 94110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.